AIM - AIM ImmunoTech Inc
IEX Last Trade
0.3481
-0.012 -3.390%
Share volume: 131,020
Last Updated: Fri 30 Aug 2024 09:35:34 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.36
-0.01
-3.28%
Summary score
18%
Profitability
0%
Dept financing
8%
Liquidity
71%
Performance
25%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-24.85%
Return on assets
-15.86%
Return on sales
-13968.94%
Return on invested capital
-175.7%
Total debt ratio
12.3%
Debt ratio change over timeo
-1.04%
Current Ratio
33.06%
Quick Ratio
32.45%
Cash Position Ratio
31.62%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-73.57%
Return on assets
-38.3%
Return on sales
-16653.27%
Return on invested capital
-439.46%
Total debt ratio
36.65%
Debt ratio change over timeo
-0.86%
Current Ratio
4.41%
Quick Ratio
4.41%
Cash Position Ratio
4.3%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-120.53%
Return on assets
-35.42%
Return on sales
-14335%
Return on invested capital
116.5%
Total debt ratio
70.19%
Debt ratio change over time
-0.79%
Current Ratio
1.14%
Quick Ratio
1.14%
Cash Position Ratio
1.11%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-93.17%
Return on assets
-89.85%
Return on sales
25517.31%
Return on invested capital
6.46%
Total debt ratio
-104.29%
Debt ratio change over time
-1.04%
Current Ratio
-99.65%
Quick Ratio
-97.36%
Cash Position Ratio
-97.49%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | AIM | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -24.85% | 13.79% | 34.47% | 7.43% |
| Return on assets | -15.86% | 2.76% | 3.15% | 5.62% |
| Return on sales | -13968.94% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | -175.7% | 2.36% | 5.39% | 19.77% |
| Profitability | 0% | 43% | 66% | 80% |
| Total debt ratio | 12.3% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -1.04% | 308.97% | -6.99% | 1.18% |
| Dept financing | 3% | 50% | 25% | 7% |
| Current Ratio | 4.41% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 4.41% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 4.3% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 2% | 3% | 8% |
| Short-term ratios | AIM | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -73.57% | 13.77% | 13.25% | 3.8% |
| Return on assets | -38.3% | 2.43% | 1.89% | 3.09% |
| Return on sales | -16653.27% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | -439.46% | 2.14% | 3.39% | 9.18% |
| Profitability | 0% | 71% | 68% | 82% |
| Total debt ratio | 36.65% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -0.86% | 46.38% | -72.08% | 1.51% |
| Dept financing | 10% | 50% | 25% | 7% |
| Current Ratio | 4.41% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 4.41% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 4.3% | 0.36% | 1.28% | 2.93% |
| Liquididy | 69% | 11% | 27% | 67% |